Quarterly report pursuant to Section 13 or 15(d)

Earnings Per Share ("EPS") (Details 2)

v3.21.2
Earnings Per Share ("EPS") (Details 2) - shares
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Conversion of common units        
Antidilutive securities        
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,262 1,240 1,257 1,235
Conversion of redeemable noncontrolling interests        
Antidilutive securities        
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 782 973 793 954
Conversion of Series I preferred units        
Antidilutive securities        
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 0 176 0 176
Weighted average restricted shares and deferred shares        
Antidilutive securities        
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 410 429 416 432
Weighted average unvested TB-PIUs        
Antidilutive securities        
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares) 168 91 155 85
Weighted average unvested PB-PIUs        
Antidilutive securities        
Weighted average antidilutive securities excluded from computation of diluted earnings per share (in shares)     228